Thryv Therapeutics
Edit

Thryv Therapeutics

https://www.lqttrx.com/
Last activity: 06.01.2022
Tags:CauseHealthTechLife
Thryv Therapeutics is developing therapies for genetic heart diseases pioneering a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.
Mentions
8
Location: Canada, Quebec, Laval
Employees: 11-50
Total raised: $19M
Founded date: 2019

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
10.08.2021Series A$19M-prnewswire...

Mentions in press and media 8

DateTitleDescriptionSource
06.01.2022LQT Therapeutics Announces Award by the European Joint Progr...Closing the gap between industry and academia to place patients directly at the center of research e...lumiravent...
01.11.2021LQT Therapeutics Announces the Appointment of Dr. Robert Boo...Company Strategically Strengthens its Fight Against Long QT Syndrome with Novel Kinase Drug Developm...lumiravent...
10.08.2021LQT Therapeutics Announces Closing of US$19M Series A Financ... - Company established with world-class research from leading academia and industry leaders- Lead p...prnewswire...
10.08.2021LQT Therapeutics secures $19M to tackle heart diseases with ...LQT Therapeutics wants to tackle debilitating heart arrhythmias with limited interventions, and inve...fiercebiot...
10.08.2021Lumira Ventures invests in LQT Therapeutics US$19M Series A ...LQT Therapeutics, Inc. (LQTT) a pharmaceutical company pioneering the development of precision thera...lumiravent...
10.08.2021LQT Therapeutics secures $19M to tackle heart diseases with ...LQT Therapeutics wants to tackle debilitating heart arrhythmias with limited interventions, and inve...fiercebiot...
09.08.2021LQT Therapeutics Announces Closing of US$19M Series A Financ...-amzakhealt...
-LQT Therapeutics“Thryv Therapeutics (previously LQT Therapeutics), has been pioneering a precision medicine approach...fastfounde...